Search
for
Sort by
Research 301–330 of 1000+
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Platelet-rich Plasma and Its Application in Clinical Trial
- O-11 DIAGNOSTIC CHALLENGES IN POSTMENOPAUSAL HYPERANDROGENISM: REPORTS OF TWO CASES
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Southern African HIV Clinicians Society gender-affirming healthcare guideline for South Africa
- Advancements and Applications of Injectable Hydrogel Composites in Biomedical Research and Therapy
- FFA Patient Profile Analysis Based on the Authors’ Observations and a Review of the Literature—An Original Survey
- The Multiple Consequences of Obesity
- Advancements in Therapeutic Deep Eutectic Solvents as Multifunctional Transdermal Delivery Systems
- Clinical Applications of Extracellular Vesicles: Promises and Pitfalls
- MANAGING ESTROGEN-DEFICIENT SKIN: A NARRATIVE REVIEW ON THE ROLE OF HRT AND EMERGING ESTROGEN-MODULATING THERAPIES
- Polycystic Ovary Syndrome (PCOS): Causes, Symptoms, Diagnosis & Treatments
- The role of mutations on gene AR, in androgenetic alopecia syndrome
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Cutaneous manifestation of polycystic ovary syndrome
- Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Comprehensive clinical management of hirsutism
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Treatment of hyperandrogenism in women
- Polycystic Ovary Syndrome and Alteration of Vocal Function: A Systematic Review and Meta-Analysis
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Polycystic Ovary Syndrome
- Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36)
- The effect of menopause on the skin and other connective tissues
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- Mood disorders and quality of life in polycystic ovary syndrome